Mento P F, Pica M E, Hilepo J, Chang J, Hirsch L, Wilkes B M
Division of Nephrology and Hypertension, Department of Medicine, North Shore University Hospital, and Department of Medicine, New York University School of Medicine, Manhasset, New York 11030, USA.
Am J Physiol. 1998 Oct;275(4):H1247-53. doi: 10.1152/ajpheart.1998.275.4.H1247.
Rats with congestive heart failure demonstrate striking intrarenal vasoconstriction that contributes to reduced renal excretory function. We previously demonstrated that inhibition of angiotensin action reverses intrarenal vasoconstriction in rats 4-6 wk after coronary artery ligation. In the present study we tested the hypothesis that abnormalities in the expression and regulation of glomerular angiotensin receptors contribute to the intrarenal vasoconstriction. Because glomerular angiotensin type 1 (AT1) receptors normally downregulate in response to high local ANG II concentrations, we anticipated that glomerular AT1-receptor expression would be reduced in rats after myocardial infarction (MI). To our surprise, the density of glomerular AT1 receptors was nearly double (97% increase, P < 0.002) that of controls, indicating an acquired abnormality in angiotensin receptor regulation. This was specific for renal glomeruli, because the density of angiotensin receptors on renal vasculature was decreased in rats after MI compared with normal controls. Glomerular AT1-receptor expression was downregulated by an acute pharmacological infusion of ANG II and upregulated by acute angiotensin-converting enzyme inhibition to a similar extent in MI and control rats. Renal cortical mRNA expression showed an increase in the renin mRNA-to-actin ratio and angiotensinogen-to-actin ratio, indicating stimulation of the intrarenal angiotensin system in rats after MI. The data indicate a specific dysregulation of AT1 receptors in glomeruli but not blood vessels after MI.
患有充血性心力衰竭的大鼠表现出显著的肾内血管收缩,这导致肾排泄功能降低。我们先前证明,抑制血管紧张素作用可逆转冠状动脉结扎后4 - 6周大鼠的肾内血管收缩。在本研究中,我们检验了肾小球血管紧张素受体表达和调节异常导致肾内血管收缩的假说。由于肾小球1型血管紧张素(AT1)受体通常会因局部高浓度血管紧张素II而发生下调,我们预期心肌梗死(MI)后大鼠的肾小球AT1受体表达会降低。令我们惊讶的是,肾小球AT1受体的密度几乎是对照组的两倍(增加97%,P < 0.002),这表明血管紧张素受体调节存在后天性异常。这在肾肾小球中具有特异性,因为与正常对照组相比,MI后大鼠肾血管系统上的血管紧张素受体密度降低。在MI大鼠和对照大鼠中,急性药理学输注血管紧张素II可下调肾小球AT1受体表达,而急性血管紧张素转换酶抑制可上调肾小球AT1受体表达,且上调程度相似。肾皮质mRNA表达显示肾素mRNA与肌动蛋白的比值以及血管紧张素原与肌动蛋白的比值增加,表明MI后大鼠肾内血管紧张素系统受到刺激。数据表明MI后肾小球而非血管中AT1受体存在特异性失调。